Insider Transactions in Q1 2021 at Sana Biotechnology, Inc. (SANA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2021
|
James J. Mac Donald EVP & General Counsel |
BUY
Conversion of derivative security
|
Indirect |
7,812
+50.0%
|
-
|
|
Feb 08
2021
|
James J. Mac Donald EVP & General Counsel |
BUY
Conversion of derivative security
|
Direct |
93,750
+17.94%
|
-
|
|
Feb 08
2021
|
Geoffrey Von Maltzahn Director |
BUY
Conversion of derivative security
|
Indirect |
366,122
+50.0%
|
-
|
|
Feb 08
2021
|
Geoffrey Von Maltzahn Director |
BUY
Conversion of derivative security
|
Direct |
1,464,488
+50.0%
|
-
|
|
Feb 08
2021
|
Steve Harr President & CEO |
BUY
Conversion of derivative security
|
Direct |
2,031,250
+19.9%
|
-
|
|
Feb 08
2021
|
Robert Nelsen |
BUY
Conversion of derivative security
|
Indirect |
43,750,000
+49.82%
|
-
|
|
Feb 08
2021
|
Hans Edgar Bishop |
BUY
Conversion of derivative security
|
Direct |
2,031,250
+26.15%
|
-
|
|
Feb 08
2021
|
Arch Venture Fund X, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
87,500,000
+49.82%
|
-
|
|
Feb 08
2021
|
Flagship Ventures Fund V General Partner LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
34,239,018
+50.0%
|
-
|
|
Feb 03
2021
|
Joshua H. Bilenker |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$500,000
$25.0 P/Share
|